CAN Opposes CMS’ Decision Regarding Monoclonal Antibodies Directed Against Amyloid for Treatment of Alzheimer’s Disease
Representing millions of family caregivers of loved ones with Alzheimer’s disease, Caregiver Action Network (CAN) is strongly disappointed with CMS’ decision regarding Coverage with Evidence Development (CED) for potential life-changing Alzheimer’s drugs. We believe that this decision will deny Medicare beneficiaries access to a ground-breaking therapy where there are no alternatives. This goes against Caregiver […]










